A detailed history of Assetmark, Inc transactions in Zimmer Biomet Holdings, Inc. stock. As of the latest transaction made, Assetmark, Inc holds 20,141 shares of ZBH stock, worth $2.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,141
Previous 26,939 25.23%
Holding current value
$2.23 Million
Previous $2.92 Million 25.62%
% of portfolio
0.01%
Previous 0.01%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$104.47 - $116.17 $710,187 - $789,723
-6,798 Reduced 25.23%
20,141 $2.17 Million
Q2 2024

Aug 13, 2024

BUY
$106.25 - $130.01 $304,300 - $372,348
2,864 Added 11.9%
26,939 $2.92 Million
Q1 2024

May 06, 2024

SELL
$119.98 - $132.61 $1.4 Million - $1.55 Million
-11,690 Reduced 32.69%
24,075 $3.18 Million
Q4 2023

Feb 09, 2024

BUY
$102.72 - $121.7 $131,481 - $155,776
1,280 Added 3.71%
35,765 $4.35 Million
Q3 2023

Oct 27, 2023

SELL
$110.76 - $143.18 $168,133 - $217,347
-1,518 Reduced 4.22%
34,485 $3.87 Million
Q2 2023

Aug 11, 2023

SELL
$126.43 - $145.6 $6,574 - $7,571
-52 Reduced 0.14%
36,003 $5.24 Million
Q1 2023

May 05, 2023

BUY
$121.91 - $130.94 $300,751 - $323,028
2,467 Added 7.34%
36,055 $4.66 Million
Q4 2022

Feb 10, 2023

BUY
$104.7 - $128.4 $1.2 Million - $1.47 Million
11,414 Added 51.47%
33,588 $4.28 Million
Q3 2022

Nov 01, 2022

BUY
$101.65 - $119.27 $774,674 - $908,956
7,621 Added 52.37%
22,174 $2.32 Million
Q2 2022

Aug 03, 2022

BUY
$102.23 - $133.85 $1.06 Million - $1.38 Million
10,327 Added 244.37%
14,553 $1.53 Million
Q1 2022

May 13, 2022

BUY
$108.42 - $129.58 $243,294 - $290,777
2,244 Added 113.22%
4,226 $541,000
Q4 2021

Feb 14, 2022

BUY
$115.43 - $146.63 $179,378 - $227,863
1,554 Added 363.08%
1,982 $252,000
Q3 2021

Nov 12, 2021

BUY
$136.35 - $158.76 $22,906 - $26,671
168 Added 64.62%
428 $63,000
Q2 2021

Aug 16, 2021

SELL
$152.95 - $173.41 $24,166 - $27,398
-158 Reduced 37.8%
260 $42,000
Q1 2021

May 14, 2021

SELL
$148.16 - $159.71 $18,223 - $19,644
-123 Reduced 22.74%
418 $67,000
Q4 2020

Feb 10, 2021

BUY
$128.25 - $151.41 $19,494 - $23,014
152 Added 39.07%
541 $83,000
Q3 2020

Nov 13, 2020

BUY
$113.59 - $141.68 $4,316 - $5,383
38 Added 10.83%
389 $53,000
Q2 2020

Aug 11, 2020

SELL
$87.02 - $133.4 $897,263 - $1.38 Million
-10,311 Reduced 96.71%
351 $42,000
Q1 2020

May 12, 2020

BUY
$78.28 - $155.73 $752,975 - $1.5 Million
9,619 Added 922.24%
10,662 $1.08 Million
Q4 2019

Feb 11, 2020

SELL
$127.4 - $146.83 $2,930 - $3,377
-23 Reduced 2.16%
1,043 $156,000
Q3 2019

Nov 13, 2019

SELL
$113.33 - $138.46 $52,131 - $63,691
-460 Reduced 30.14%
1,066 $146,000
Q2 2019

Aug 14, 2019

SELL
$108.87 - $125.09 $27,435 - $31,522
-252 Reduced 14.17%
1,526 $180,000
Q1 2019

May 14, 2019

SELL
$97.5 - $125.79 $1,462 - $1,886
-15 Reduced 0.84%
1,778 $227,000
Q4 2018

Feb 13, 2019

BUY
$94.4 - $126.76 $146,886 - $197,238
1,556 Added 656.54%
1,793 $186,000
Q3 2018

Nov 13, 2018

SELL
$108.41 - $127.64 $18,646 - $21,954
-172 Reduced 42.05%
237 $31,000
Q2 2018

Aug 01, 2018

SELL
$102.12 - $114.04 $4,493 - $5,017
-44 Reduced 9.71%
409 $46,000
Q1 2018

May 16, 2018

SELL
$104.31 - $124.46 $18,567 - $22,153
-178 Reduced 28.21%
453 $49,000
Q4 2017

Feb 13, 2018

BUY
$105.55 - $120.83 $10,766 - $12,324
102 Added 19.28%
631 $76,000
Q3 2017

Nov 08, 2017

BUY
$106.92 - $117.79 $3,528 - $3,887
33 Added 6.65%
529 $62,000
Q2 2017

Aug 15, 2017

SELL
N/A
-35 Reduced 6.59%
496 $64,000
Q1 2017

Sep 15, 2017

SELL
N/A
-4 Reduced 0.75%
531 $65,000
Q4 2016

Sep 15, 2017

BUY
N/A
34 Added 6.79%
535 $55,000
Q3 2016

Sep 15, 2017

BUY
N/A
111 Added 28.46%
501 $65,000
Q2 2016

Sep 15, 2017

BUY
N/A
33 Added 9.24%
390 $47,000
Q1 2016

Sep 15, 2017

BUY
N/A
46 Added 14.79%
357 $38,000
Q4 2015

Sep 15, 2017

BUY
N/A
311
311 $32,000

Others Institutions Holding ZBH

About ZIMMER BIOMET HOLDINGS, INC.


  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.3B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.